Washington
+919405476170
+919359902383
General Medicine by Miratide

Mirabegron 50 mg Tablet

In stock•cod not available
Phone Number

+919359902383

Mon-Thu: 10 AM - 2 PM • Fri: 3 PM - 7AM

Other Website Visit our other website
Address Washington D.C., DC, USA

Washington, United States, 20001

Description

Miratide 50 mg Mirabegron Extended Release Tablet | USA Supply Product Name: Miratide 50 mg Brand Name: Miratide Generic Name: Mirabegron Active Content Name: Mirabegron Composition: Mirabegron 50 mg Strength: 50 mg Dosage Form: Extended-Release Tablet Medicine Category: Urology Medicines Therapeutic Category: Overactive Bladder Management Drug Class: Beta-3 Adrenergic Receptor Agonist Route of Administration: Oral Understanding Mirabegron 50 mg Mirabegron is a medicine used for bladder-related conditions, particularly overactive bladder. Unlike antimuscarinic medicines, it works primarily by stimulating beta-3 adrenergic receptors in the bladder. The extended-release formulation is designed to release the medicine gradually rather than all at once. Tablets should therefore be taken according to the prescribing information and should not be crushed or altered unless the official product instructions specifically permit it. How Mirabegron Works During the bladder's storage phase, activation of beta-3 adrenergic receptors helps relax the detrusor smooth muscle. This can improve the bladder's ability to store urine and help manage symptoms associated with overactive bladder. What Makes the Extended-Release Formulation Important? Miratide is identified as an extended-release tablet. This formulation is intended to provide controlled release of the active ingredient over time. The tablet should be handled according to the original product label. Patients should not independently change the dosage, frequency, or tablet administration method. When Mirabegron May Be Prescribed Mirabegron may be prescribed for adults with overactive bladder symptoms such as urinary urgency, increased urinary frequency, and urge urinary incontinence. The appropriate indication and treatment plan should always be determined by a qualified healthcare professional. Possible Side Effects Reported adverse effects associated with mirabegron can include increased blood pressure, headache, urinary tract infection, and nasopharyngitis. Other reactions can occur, and patients experiencing persistent or unusual symptoms should seek medical advice. Major U.S. Markets Covered Professional pharmaceutical inquiries may be considered from businesses serving New York City, New York; Los Angeles, California; Chicago, Illinois; Houston, Texas; and Phoenix, Arizona, as well as other U.S. locations where applicable. FAQs 1. What is Miratide 50 mg? Miratide 50 mg is an extended-release tablet containing Mirabegron 50 mg, a medicine belonging to the beta-3 adrenergic receptor agonist class. 2. What therapeutic category does Miratide belong to? It falls under urology medicines, particularly medicines used for managing overactive bladder symptoms. 3. How does Mirabegron work in the bladder? Mirabegron activates beta-3 adrenergic receptors, helping the bladder muscle relax during the urine-storage phase. 4. What does “extended release” mean for Miratide? It means the formulation is designed to release the active ingredient gradually over an extended period. 5. Should Miratide extended-release tablets be crushed? Extended-release tablets generally need to be swallowed intact. The instructions on the specific product label or prescribing information should be followed. 6. Can Mirabegron affect blood pressure? Yes. Mirabegron can increase blood pressure in some patients, which is why monitoring may be appropriate during treatment. 7. What information should be checked on a Miratide pack? The pack should be reviewed for the active ingredient, strength, extended-release designation, manufacturer, batch number, expiry date, and storage instructions. 8. Is Mirabegron the same type of medicine as an antimuscarinic? No. Mirabegron works primarily as a beta-3 adrenergic receptor agonist and has a different mechanism from antimuscarinic bladder medicines. 9. Does the 50 mg strength determine how every patient should take Miratide? No. Treatment selection and dosing depend on individual clinical factors and should follow a healthcare professional's instructions and applicable prescribing information. 10. Why is Mirabegron classified as a beta-3 adrenergic receptor agonist? Mirabegron primarily works by activating beta-3 adrenergic receptors in the bladder, helping the detrusor muscle relax during the bladder-filling phase. Mirabegron 50mg Tablet, Mirabegron Extended Release Tablet 50mg, Mirabegron ER 50mg Tablet, Mirabegron Extended Release Tablets, Mirabegron 50mg ER, Mirabegron 50mg Wholesale Supplier, Mirabegron 50mg Bulk Supply, Mirabegron Tablet Exporter from India, Mirabegron ER Tablet Supplier.

Keywords

Other Products

view all

68179d65be22ee500d53ff54 Card 2

product image
General Medicine

Predniheal 20 mg Prednisolone Tablets for USA Healthcare Procurement Prednisolone Tablets IP 20mg Predniheal 20mg is an oral corticosteroid medicine containing Prednisolone 20mg. Prednisolone has anti-inflammatory and immunosuppressive activity and is prescribed for a range of conditions where modification of inflammatory or immune responses is clinically appropriate. Unlike medicines intended for a single disease, corticosteroids can be used across different specialties. The reason for prescribing Predniheal therefore depends on the patient's diagnosis, treatment objectives, and professional assessment. Product Name: Predniheal 20 mg Brand Name: Predniheal Generic Name: Prednisolone Active Content Name: Prednisolone Composition: Prednisolone 20 mg Strength: 20 mg Pharmacopoeial Standard: IP, as provided Dosage Form: Tablet Medicine Category: Corticosteroids Therapeutic Segment: Anti-inflammatory / Immunosuppressive Medicines Drug Class: Glucocorticoid Route of Administration: Oral Clinical Areas Where Prednisolone May Be Used Prednisolone is prescribed in a variety of inflammatory, allergic, autoimmune and immune-mediated conditions. Depending on the diagnosis and applicable prescribing information, corticosteroid therapy may be considered in certain respiratory, rheumatological, dermatological, allergic, hematological and other inflammatory disorders. Why Corticosteroid Treatment Requires Individual Assessment Corticosteroid dosing is not the same for every patient. The appropriate dose can depend on the disease being treated, severity, treatment duration, response, and other medicines or health conditions. Longer treatment courses may also require gradual dose reduction rather than abrupt discontinuation. Patients should follow the prescribing clinician's instructions. Possible Adverse Effects Reported effects of systemic prednisolone can include increased appetite, indigestion, mood or sleep changes, fluid retention, and changes in blood glucose. Predniheal 20 mg enquiries may come from qualified pharmaceutical businesses, distributors, and institutional procurement channels serving the U.S. market. Before proceeding with procurement, buyers should establish the exact manufacturer, pack configuration, batch details, expiry, product labeling, documentation, and applicable U.S. regulatory/import status. Major U.S. Cities Covered: across New York City, New York; Los Angeles, California; Chicago, Illinois; Houston, Texas; and Phoenix, Arizona. Frequently Asked Questions 1. What does Predniheal 20 mg contain? Predniheal contains Prednisolone 20 mg as the active ingredient, based on the product information provided. 2. Which medicine category does Predniheal belong to? It belongs to the corticosteroid group of medicines and is specifically classified as a glucocorticoid. 3. Why is Prednisolone used in inflammatory conditions? Prednisolone modifies inflammatory and immune activity, which can help control inflammation in conditions where corticosteroid therapy is clinically appropriate. 4. Is Predniheal 20 mg intended for oral administration? Yes. The supplied product information identifies Predniheal as a tablet formulation containing Prednisolone 20 mg. 5. Can Prednisolone affect the body's immune response? Yes. Systemic corticosteroids can suppress aspects of immune activity, which is one reason their use requires appropriate medical supervision. 6. Can Prednisolone influence blood glucose levels? Yes. Corticosteroids can increase blood glucose in some patients, particularly during higher-dose or prolonged treatment. 7. Why should long-term Prednisolone therapy be medically monitored? Extended corticosteroid use can affect several areas of health, including bone metabolism, blood pressure, glucose regulation, infection susceptibility and adrenal function. 8. Can Predniheal be stopped suddenly after prolonged treatment? Abrupt discontinuation may be inappropriate after prolonged systemic corticosteroid therapy. Dose reduction should follow the prescribing healthcare professional's instructions. 9. What product details should be reviewed before professional procurement? The original packaging should be checked for the manufacturer, composition, strength, batch number, expiry date, pack configuration, storage conditions and labeling information. 10. Does every inflammatory condition require Prednisolone treatment? No. The need for corticosteroid treatment depends on the diagnosis, severity, patient-specific factors and professional clinical assessment. Predniheal 20 mg Tablet, Prednisolone 20 mg Tablet USA, Prednisolone Tablets IP, Prednisolone Corticosteroid Tablet, Oral Corticosteroid Medicine, Glucocorticoid Tablet USA, Prednisolone Anti-inflammatory Medicine, Prednisolone Tablet New York,

68179d65be22ee500d53ff54 Card 2

product image
General Medicine

Miratide 50 mg Mirabegron Extended Release Tablet | USA Supply Product Name: Miratide 50 mg Brand Name: Miratide Generic Name: Mirabegron Active Content Name: Mirabegron Composition: Mirabegron 50 mg Strength: 50 mg Dosage Form: Extended-Release Tablet Medicine Category: Urology Medicines Therapeutic Category: Overactive Bladder Management Drug Class: Beta-3 Adrenergic Receptor Agonist Route of Administration: Oral Understanding Mirabegron 50 mg Mirabegron is a medicine used for bladder-related conditions, particularly overactive bladder. Unlike antimuscarinic medicines, it works primarily by stimulating beta-3 adrenergic receptors in the bladder. The extended-release formulation is designed to release the medicine gradually rather than all at once. Tablets should therefore be taken according to the prescribing information and should not be crushed or altered unless the official product instructions specifically permit it. How Mirabegron Works During the bladder's storage phase, activation of beta-3 adrenergic receptors helps relax the detrusor smooth muscle. This can improve the bladder's ability to store urine and help manage symptoms associated with overactive bladder. What Makes the Extended-Release Formulation Important? Miratide is identified as an extended-release tablet. This formulation is intended to provide controlled release of the active ingredient over time. The tablet should be handled according to the original product label. Patients should not independently change the dosage, frequency, or tablet administration method. When Mirabegron May Be Prescribed Mirabegron may be prescribed for adults with overactive bladder symptoms such as urinary urgency, increased urinary frequency, and urge urinary incontinence. The appropriate indication and treatment plan should always be determined by a qualified healthcare professional. Possible Side Effects Reported adverse effects associated with mirabegron can include increased blood pressure, headache, urinary tract infection, and nasopharyngitis. Other reactions can occur, and patients experiencing persistent or unusual symptoms should seek medical advice. Major U.S. Markets Covered Professional pharmaceutical inquiries may be considered from businesses serving New York City, New York; Los Angeles, California; Chicago, Illinois; Houston, Texas; and Phoenix, Arizona, as well as other U.S. locations where applicable. FAQs 1. What is Miratide 50 mg? Miratide 50 mg is an extended-release tablet containing Mirabegron 50 mg, a medicine belonging to the beta-3 adrenergic receptor agonist class. 2. What therapeutic category does Miratide belong to? It falls under urology medicines, particularly medicines used for managing overactive bladder symptoms. 3. How does Mirabegron work in the bladder? Mirabegron activates beta-3 adrenergic receptors, helping the bladder muscle relax during the urine-storage phase. 4. What does “extended release” mean for Miratide? It means the formulation is designed to release the active ingredient gradually over an extended period. 5. Should Miratide extended-release tablets be crushed? Extended-release tablets generally need to be swallowed intact. The instructions on the specific product label or prescribing information should be followed. 6. Can Mirabegron affect blood pressure? Yes. Mirabegron can increase blood pressure in some patients, which is why monitoring may be appropriate during treatment. 7. What information should be checked on a Miratide pack? The pack should be reviewed for the active ingredient, strength, extended-release designation, manufacturer, batch number, expiry date, and storage instructions. 8. Is Mirabegron the same type of medicine as an antimuscarinic? No. Mirabegron works primarily as a beta-3 adrenergic receptor agonist and has a different mechanism from antimuscarinic bladder medicines. 9. Does the 50 mg strength determine how every patient should take Miratide? No. Treatment selection and dosing depend on individual clinical factors and should follow a healthcare professional's instructions and applicable prescribing information. 10. Why is Mirabegron classified as a beta-3 adrenergic receptor agonist? Mirabegron primarily works by activating beta-3 adrenergic receptors in the bladder, helping the detrusor muscle relax during the bladder-filling phase. Mirabegron 50mg Tablet, Mirabegron Extended Release Tablet 50mg, Mirabegron ER 50mg Tablet, Mirabegron Extended Release Tablets, Mirabegron 50mg ER, Mirabegron 50mg Wholesale Supplier, Mirabegron 50mg Bulk Supply, Mirabegron Tablet Exporter from India, Mirabegron ER Tablet Supplier.

68179d65be22ee500d53ff54 Card 2

product image
General Medicines

Nutrabod Largibine 1000 mg | Nutritional Supplement Supply USA L-Arginine is an amino acid used by the body in several biological processes. One of its important roles is serving as a precursor for nitric oxide, a signaling molecule involved in normal blood-vessel function. The body can produce arginine, and it is also obtained through dietary sources. Supplementation should not be presented as a substitute for a balanced diet or medical treatment. Product Name: Nutrabod Largibine 1000 mg Stated Ingredient: L-Arginine Stated Strength: 1000 mg Dosage Form: Tablet Product Segment: Amino Acid / Nutritional Supplement Ingredient Category: Amino Acid Administration Route: Oral Storage & Handling Keep Nutrabod Largibine in its original packaging and follow the manufacturer's storage directions. Protect the product from unsuitable environmental conditions and keep it away from children. For wholesale transportation and warehousing, the conditions printed on the original product label should take priority over generic storage recommendations. Safety Considerations L-Arginine supplements may not be appropriate for everyone. People taking prescription medicines or those with cardiovascular, blood-pressure, kidney, or other medical conditions should discuss supplement use with a qualified healthcare professional. Documentation Support for U.S. B2B Enquiries Depending on the product and transaction, available documentation may include: Commercial Invoice | Packing List | Batch/Product Details | Certificate of Analysis (COA), where available | Certificate of Origin, where applicable | Shipping Documents FAQs 1. What is Nutrabod Largibine 1000 mg? It is presented as an L-Arginine-based tablet with a stated strength of 1000 mg. The complete composition should be confirmed from the pack. 2. What is L-Arginine? L-Arginine is an amino acid involved in several normal physiological processes, including nitric oxide synthesis. 3. What is the stated strength of Largibine? The supplied product name states 1000 mg. The exact basis of this strength should be checked on the manufacturer's label. 4. Is Nutrabod Largibine a prescription medicine? The exact regulatory/product classification should be confirmed from its packaging and for the destination market rather than assumed. 5. Is L-Arginine naturally present in the body? Yes. Arginine is an amino acid that can be produced by the body and obtained from dietary sources. 6. Can L-Arginine supplements replace medical treatment? No. Nutritional supplements should not be presented as substitutes for prescribed medical treatment. 7. What should be checked on the Nutrabod Largibine label before use? Check the complete ingredient list, serving information, stated strength, expiry date, storage instructions, and product warnings provided on the original packaging. 8. Why is L-Arginine included in nutritional supplements? L-Arginine is an amino acid involved in normal physiological processes, including protein metabolism and nitric oxide production in the body. 9. What role does nitric oxide play in relation to L-Arginine? L-Arginine acts as a precursor for nitric oxide, a signaling molecule involved in normal blood-vessel function. 10. Is L-Arginine obtained only through supplements? No. L-Arginine is also naturally present in various protein-containing foods, while the body can produce it under normal circumstances. Nutrabod Largibine 1000 mg L-Arginine 1000 mg Tablet USA L-Arginine Supplement Supplier USA Nutrabod Largibine Supplier USA L-Arginine Tablet Wholesale USA Amino Acid Supplement Supplier USA Nutritional Supplement Supplier USA L-Arginine B2B Supply USA